EP0662782A4 - Pp14-based therapy. - Google Patents

Pp14-based therapy.

Info

Publication number: EP0662782A4
Authority: EP; European Patent Office
Prior art keywords: based therapy; therapy
Prior art date: 1992-09-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP93922763A

Other languages

German (de)

French (fr)

Other versions

EP0662782A1 (en

Inventor

Mark L Tykocinski

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-09-30

Filing date

1993-09-28

Publication date

1995-10-25

1993-09-28 Application filed by Individual filed Critical Individual

1995-07-19 Publication of EP0662782A1 publication Critical patent/EP0662782A1/en

1995-10-25 Publication of EP0662782A4 publication Critical patent/EP0662782A4/en

Status Withdrawn legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/74—Inducing cell proliferation

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Zoology (AREA)
Transplantation (AREA)
Pregnancy & Childbirth (AREA)
Diabetes (AREA)
Cell Biology (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Gynecology & Obstetrics (AREA)
Hematology (AREA)
Reproductive Health (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

EP93922763A 1992-09-30 1993-09-28 Pp14-based therapy. Withdrawn EP0662782A4 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US95480292A	1992-09-30	1992-09-30
US954802		1992-09-30
PCT/US1993/009216 WO1994007366A1 (en)	1992-09-30	1993-09-28	Pp14-based therapy

Publications (2)

Publication Number	Publication Date
EP0662782A1 EP0662782A1 (en)	1995-07-19
EP0662782A4 true EP0662782A4 (en)	1995-10-25

Family

ID=25495948

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP93922763A Withdrawn EP0662782A4 (en)	1992-09-30	1993-09-28	Pp14-based therapy.

Country Status (5)

Country	Link
EP (1)	EP0662782A4 (en)
JP (1)	JPH08502257A (en)
AU (1)	AU5165993A (en)
CA (1)	CA2145762A1 (en)
WO (1)	WO1994007366A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL111743A0 (en) *	1993-12-08	1995-01-24	Intermune Life Sciences Inc	Recombinant genes expressing pp14
EP1248552A4 (en) *	2000-01-03	2004-11-17	Tr Associates L L C	Pp14 fusion proteins and methods for making and using the same
WO2004093907A2 (en) *	2003-04-23	2004-11-04	Tomoaki Hoshino	Therapeutic agents for treating dermatitis, alopecia and itching and transgenic animals for evaluating such therapeutic agents

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0378418A2 (en) *	1989-01-11	1990-07-18	Intermune Life Sciences, Inc.	Immune cell proliferation inhibitors

1993
- 1993-09-28 CA CA002145762A patent/CA2145762A1/en not_active Abandoned
- 1993-09-28 EP EP93922763A patent/EP0662782A4/en not_active Withdrawn
- 1993-09-28 AU AU51659/93A patent/AU5165993A/en not_active Abandoned
- 1993-09-28 WO PCT/US1993/009216 patent/WO1994007366A1/en not_active Ceased
- 1993-09-28 JP JP6509255A patent/JPH08502257A/en active Pending

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0378418A2 (en) *	1989-01-11	1990-07-18	Intermune Life Sciences, Inc.	Immune cell proliferation inhibitors

Also Published As

Publication number	Publication date
JPH08502257A (en)	1996-03-12
WO1994007366A1 (en)	1994-04-14
EP0662782A1 (en)	1995-07-19
AU5165993A (en)	1994-04-26
CA2145762A1 (en)	1994-04-14

Legal Events

Date	Code	Title	Description
1995-06-02	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1995-07-19	17P	Request for examination filed	Effective date: 19950428
1995-07-19	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
1995-10-25	A4	Supplementary search report drawn up and despatched	Effective date: 19950912
1995-10-25	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
1995-10-25	RHK1	Main classification (correction)	Ipc: C12N 15/10
1998-09-04	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
1998-10-21	18D	Application deemed to be withdrawn	Effective date: 19980401

Publication	Publication Date	Title
EP0597463A3 (en)	1996-11-06	Thermotherapiesonde.
EP0580285A3 (en)	1995-05-03	Auto-reclosers.
GR3025363T3 (en)	1998-02-27	Medicaments.
GR3022484T3 (en)	1997-05-31	Osteosynthesis aid.
EP0666752A4 (en)	1996-09-11	Therapeutic microemulsions.
GB9203039D0 (en)	1992-03-25	Treatment
EP0599191A3 (en)	1995-02-08	Speed-governor-circuit.
PH31659A (en)	1999-01-12	Therapeutic nucleotides.
ZA946217B (en)	1996-02-19	Therapeutic combination
EP0662782A4 (en)	1995-10-25	Pp14-based therapy.
EP0624089A4 (en)	1994-12-14	Methods.
ZA935828B (en)	1994-03-10	New insobutyl-substituted methanesulphonyl-quinolyl-methoxyphenyl-cycloalkylacetamides.
ZA929916B (en)	1993-06-23	Therapeutic agents.
GB9221450D0 (en)	1992-11-25	The wropod
ZA931403B (en)	1993-09-06	Sulphonamidocarboxamides.
GB9323437D0 (en)	1994-01-05	Therapy
EG19223A (en)	1994-09-29	Therapeutic agents.
ZA933136B (en)	1994-01-05	Therapeutic alcohols.
ZA928102B (en)	1993-04-21	Therapeutic agent.
ZA939705B (en)	1994-08-29	Inhalter devices.
GB9216088D0 (en)	1992-09-09	Therapeutic combinations
GB9210270D0 (en)	1992-07-01	Therapeutic combinations
GB9210256D0 (en)	1992-07-01	Therapeutic combinations
GB9226728D0 (en)	1993-02-17	Therapeutic combination
ZA931630B (en)	1993-10-11	Securing means.